These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4845938)

  • 1. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 2. Current good manufacturing practice regulations.
    Bumiller J
    Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094
    [No Abstract]   [Full Text] [Related]  

  • 3. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 6. A product standards form for new radipharmaceuticals.
    Warbick A
    Am J Hosp Pharm; 1974 Feb; 31(2):165-6. PubMed ID: 4815850
    [No Abstract]   [Full Text] [Related]  

  • 7. Some interpretations of controversial sub-sections in the Current Good Manufacturing Practice regulations for drug products.
    Loftus BT
    J Parenter Drug Assoc; 1979; 33(6):326-32. PubMed ID: 261583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 9. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 10. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aseptic process monitoring--a better strategy. Validation Group, Inc.
    Wilson JD
    PDA J Pharm Sci Technol; 1999; 53(3):111-4. PubMed ID: 10754699
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report.
    World Health Organ Tech Rep Ser; 1975; (567):1-115. PubMed ID: 807046
    [No Abstract]   [Full Text] [Related]  

  • 13. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed European pharmacopeia monograph for continuous cell lines derived drugs.
    Dorpema JW
    Dev Biol Stand; 1989; 70():113-24. PubMed ID: 2759345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risks in the delivery of drugs from the point of manufacture to the patient. I. Risks in manufacturing and compounding].
    Samková M; Solich J
    Cesk Farm; 1981 Dec; 30(10):349-54. PubMed ID: 7332939
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of packaging in ethylene oxide sterilization.
    Panella JA
    Bull Parenter Drug Assoc; 1974; 28(4):188-96. PubMed ID: 4212326
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug impurities: problems and regulations.
    Pifferi G; Mannucci A
    Boll Chim Farm; 1999 Nov; 138(10):500-7. PubMed ID: 10765465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug quality through certification experience.
    Weiss PJ
    Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.